However, recent biochemical and cellular studies indicate that mammalian SMYD2 protein is an H3K36-specific HMT [63], and surprisingly, that it is able to methylate p53 on the lysine 370 and thereby inhibit the tumor suppressing function of p53 [64]. This evidence concerns the gene SMYD2 and neoplasm.